X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

NASDAQ:XFOR

Overview | Financials
Company Name X4 Pharmaceuticals, Inc.
Symbol XFOR
Currency USD
Price 0.806
Market Cap 137,408,912
Dividend Yield 0%
52-week-range 0.261 - 1.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Paula Ragan Ph.D.
Website https://www.x4pharma.com

An error occurred while fetching data.

About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical

Related Stocks

Immunome, Inc. logo

Immunome, Inc.

IMNM

11.1 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

0.37 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

2.49 USD

Nutriband Inc. logo

Nutriband Inc.

NTRB

3.95 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.19 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

11.97 USD

Financials

Numbers are in millions USD

Numbers are in millions USD